260 related articles for article (PubMed ID: 30717368)
1. Profiling of LINE-1-Related Genes in Hepatocellular Carcinoma.
Honda T; Rahman MA
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717368
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
Gong X; Wei W; Chen L; Xia Z; Yu C
Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
[TBL] [Abstract][Full Text] [Related]
3. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
4. L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.
Schauer SN; Carreira PE; Shukla R; Gerhardt DJ; Gerdes P; Sanchez-Luque FJ; Nicoli P; Kindlova M; Ghisletti S; Santos AD; Rapoud D; Samuel D; Faivre J; Ewing AD; Richardson SR; Faulkner GJ
Genome Res; 2018 May; 28(5):639-653. PubMed ID: 29643204
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
Kao JH; Chen PJ; Chen DS
Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
[TBL] [Abstract][Full Text] [Related]
7. Investigating genetic characteristics of hepatitis B virus-associated and -non-associated hepatocellular carcinoma.
Fu XH; Li M; Lou HB; Huang MS; Liu CL
Genet Res (Camb); 2016 Nov; 98():e14. PubMed ID: 27834158
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
9. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
10. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
11. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
12. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma.
Xie H; Xing C; Wei B; Xu X; Wu L; Wu J; Chen L; Cao G; Chen H; Meng X; Yin S; Zhou L; Zheng S
Tumour Biol; 2015 Nov; 36(11):8881-6. PubMed ID: 26069105
[TBL] [Abstract][Full Text] [Related]
14. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Xie Y
Adv Exp Med Biol; 2017; 1018():11-21. PubMed ID: 29052129
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer.
Bose S; Tripathi DM; Sukriti ; Sakhuja P; Kazim SN; Sarin SK
Gene; 2013 May; 519(2):231-7. PubMed ID: 23454624
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis.
Wu Z; Dong Z; Luo J; Hu W; Tong Y; Gao X; Yao W; Tian H; Wang X
Genomics; 2024 May; 116(3):110831. PubMed ID: 38513875
[TBL] [Abstract][Full Text] [Related]
18. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma.
Yu TT; Xu XM; Hu Y; Deng JJ; Ge W; Han NN; Zhang MX
World J Gastroenterol; 2015 Jun; 21(23):7208-17. PubMed ID: 26109807
[TBL] [Abstract][Full Text] [Related]
20. Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma.
Kim YR; Byun MR; Choi JW
Cancer Biomark; 2018; 23(1):135-144. PubMed ID: 30010110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]